Stay updated on Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a new version of the page content. This update reflects a minor revision to the page's documentation rather than changes to study data or eligibility criteria.SummaryDifference0.0%

- Check16 days agoChange DetectedCedars-Sinai Medical Center was added as a trial location on 2026-05-04, while Cedars Sinai Medical Center was removed earlier (2026-04-18 and 2026-04-21), reflecting updates to the study's site list.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedA previously listed study location was updated and a new facility entry (“Northwest Cancer Center - Crown Point”) is now shown with a later update date. The page also reflects a revision/version change from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check38 days agoChange DetectedPage revision updated from v3.5.0 (2026-04-08) to v3.5.2 (2026-04-13).SummaryDifference0.0%

- Check45 days agoChange DetectedAdded update dates 2026-04-08 and 2026-04-09; removed 2026-04-02 and 2026-04-03.SummaryDifference0.0%

- Check52 days agoChange DetectedUpdated the Study Record Dates with new entries for 2026-04-02 and 2026-04-03, and removed older dates 2026-03-27, 2026-03-26, and 2025-09.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.